Abstract:BACKGROUND AND AIMS: Cleidocranial dysplasia (CCD) represents a rare autosomal dominant skeletal dysplasia caused by mutations that induce haploinsufficiency in RUNX2, the important transcription factor of osteoblasts related to bone/cartilage development and maintenance. Clavicular hypoplasia, which involves aberrant tooth/craniofacial bone/skeletal formation, is a feature of classic CCD. RUNX2 mutations can be found in approximately 60-70% of patients with CCD, and around ∼10% of these mutations are microdeletions. The present paper describes the radiological and clinical characteristics of a 5-year-old girl who showed representative CCD features, including extra teeth, aplasia of clavicles, sloping shoulders, marked calvarial hypomineralization, and osteoporosis.MATERIALS AND METHODS: We obtained genomic DNA of her family members and performed whole-genome sequencing (WGS) for samples collected from the proband. Quantitative fluorescent PCR (QF-PCR) and specific PCR plus electrophoresis were then performed as validation assays for all participants. In vitro analysis was performed. Luciferase assay for Runx2 transcription activity and evaluation of mRNA levels of Runx2 downstream osteogenic markers were conducted.RESULTS: WGS identified a 11.38-kb microdeletion in RUNX2 comprising 8-9 exons, which was validated by QF-PCR and specific PCR plus electrophoresis. In vitro experiments confirmed the pathogenicity of this variation.CONCLUSION: The present study identified a 11.38-kb microdeletion in RUNX2 that causes CCD. The deletion in the PST domain of RUNX2 reduces its transcription activity and reduces osteogenic marker levels, eventually decreasing the differentiation of osteoblasts. These findings clarify the role of the CCD-related mechanism in the development of CCD and suggest that it is important to consider copy number variation for the suspected familial patients early.

A Novel 90-kbp Deletion of RUNX2 Associated with Cleidocranial Dysplasia

A Novel RUNX2 Mutation in Cleidocranial Dysplasia Patients.

Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia.

Mutation Analysis of the RUNX2 Gene in a Family with Cleidocranial Dysplasia

Effect of Cleidocranial Dysplasia‐related Novel Mutation of RUNX2 on Characteristics of Dental Pulp Cells and Tooth Development

A Novel 18-Bp In-Frame Deletion Mutation in RUNX2 Causes Cleidocranial Dysplasia

Genome sequencing identified a novel exonic microdeletion in the RUNX2 gene that causes cleidocranial dysplasia

A novel single-base deletion of the RUNX Family Transcription Factor 2 gene associated with cleidocranial dysplasia

Clinical Spectrum of Cleidocranial Dysplasia in a Family with Twins

A novel Alu-mediated microdeletion in the RUNX2 gene in a Chinese patient with cleidocranial dysplasia

A novel single-base deletion mutation of the RUNX2 gene in a Chinese family with cleidocranial dysplasia.

Identification of a Novel Mutation in the Runt-Related Transcription Factor 2 Gene in a Chinese Family With Cleidocranial Dysplasia

Mutations in the RUNX2 gene in a patient with Cleidocranial Dysplasia

Effect of the RUNX2 Gene Mutations on Subnuclear Localization of the RUNX2 Protein Mutants

Identification a novel de novo RUNX2 frameshift mutation associated with cleidocranial dysplasia

Identification of RUNX2 variants associated with cleidocranial dysplasia

Novel Runx2 Frameshift Mutations in Chinese Patients with Cleidocranial Dysplasia

Novel Mutation of Cleidocranial Dysplasia-related Frameshift Runt-related Transcription Factor 2 in a Sporadic Chinese Case.

Whole-exome sequencing identification of a novel splicing mutation of RUNX2 in a Chinese family with cleidocranial dysplasia

Novel RUNX2 Mutations in Chinese Individuals with Cleidocranial Dysplasia

Analysis of Novel RUNX2 Mutations in Chinese Patients with Cleidocranial Dysplasia